ASTRAZENECA PLC (NY:AZN)
44.11
-0 (-0%)
| ASTRAZENECA PLC (NY:AZN) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $44.11 | 52 Week High | $50.70 | ||
| Open | $44.27 | 52 Week Low | $29.96 | ||
| Day High | $44.57 | P/E | N/A | ||
| Day Low | $43.67 | EPS | $0.00 | ||
| Volume | 2,755,875 | ||||
| More AZN Info: Chart SEC Filings Profile Historical Options | |||||
AstraZeneca plc Summary
AstraZeneca PLC discovers, develops, manufactures, and markets prescription pharmaceuticals in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory and inflammation, and infection worldwide. Its products include Arimidex for hormonal breast cancer; Crestor that provides treatment for managing cholesterol levels; Nexium for acid-related diseases; Seroquel, an atypical anti-psychotic therapy for treating schizophrenia and bipolar mania; and Symbicort for the maintenance treatment of asthma in ...more
Executives
David Brennan - CEO, Director
Links
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| TRGT | 7 | SNY | 7 |
| GSK | 6 | BMY | 6 |
| NVS | 6 | NKTR | 5 |
| MYL | 5 | MOT | 4 |
| EK | 4 | CL | 4 |
| GNW | 4 | LLL | 3 |
Entities who have mentioned AZN
- Citi | View Related Stories »
- UBS | View Related Stories »
- JPMorgan | View Related Stories »
- Deutsche Bank | View Related Stories »
- Goldman Sachs | View Related Stories »
- Morgan Stanley | View Related Stories »
- Banc of America | View Related Stories »
- Jefferies & Co | View Related Stories »
- Credit Suisse | View Related Stories »
- Piper Jaffray | View Related Stories »
- Barclays | View Related Stories »
- Notable Analyst Rating Changes | View Related Stories »
- Merrill Lynch | View Related Stories »
- Goldman Sachs Conviction Buy List | View Related Stories »
- Trading Radar | View Related Stories »
- Robert W Baird | View Related Stories »
- Initial Jobless Claims | View Related Stories »
- Wachovia | View Related Stories »
- Merriman Curhan Ford | View Related Stories »
- Morgan Joseph | View Related Stories »
- Lehman Brothers | View Related Stories »
- Crude Oil | View Related Stories »
- Susquehanna International Group of Companies | View Related Stories »
- David Moenning | View Related Stories »
- Cowen & Co | View Related Stories »
View All Major News StreetInsider.com Major News for AZN
- AstraZeneca (AZN) Q4 Profits Climb, But Forecast Falls Short
- AstraZeneca plc (AZN) Tops Q3 EPS by 30c
- AstraZeneca (AZN) Tops Q2 EPS by 24c; Guides Higher
View All ReportsStreetInsider.com Reports on AZN
- AstraZeneca (AZN) Gets Additional Approval from U.S. FDA for CRESTOR
- AstraZeneca (AZN) Biz Unit MedImmune Announces Publication of Pivotal Trial for Motavizumab
- AstraZeneca (AZN) Q4 Profits Climb, But Forecast Falls Short
- Trading Radar for 01/28: Amazon.com (AMZN), Microsoft (MSFT), Chubb (CB), AT&T (T), Ford Motor (F), L-3 (LLL) Report
- Morgan Stanley Upgrades AstraZeneca, Downgrades Sanofi, Bayer (AZN, SNY, BAYRY)
View All Press ReleasesCompany Press Releases on AZN
- US FDA Approves New Indication for CRESTOR(R) (rosuvastatin calcium)
- Atlantis(TM) Patient-Specific Abutment Now Available for NobelActive(TM) Implants
- Pivotal Trial Results for Motavizumab Published in Current Issue of 'Pediatrics'
- Seroquel and Seroquel XR Will Garner Nearly One Quarter of Antipsychotics Sales for Major Depressive Disorder By 2013, Following Seroquel XR's Approval as an Adjunctive Therapy for the Indication
- Four Worksites Awarded CEO Cancer Gold StandardTM Accreditation
StreetInsider Reports on AZN by Category
View All BlogsBlogs on AZN
- Large Pharma and Small Biotech Deals Expected to Increase in 2010
- How Big Pharma Got in This Fix
- Novo Nordisk Has High Hopes for Diabetes Blockbuster
- Fourth Quarter Trends for Big Pharma
- Venture Financing Comes Through for Biotech
View All FilingsSEC Filings on AZN
- Form 6-K ASTRAZENECA PLC For: Feb 05
- Form SC 13G ASTRAZENECA PLC Filed by: BlackRock Inc.
- Form 6-K ASTRAZENECA PLC For: Jan 05
Comments on recent AZN articles
Comments on AZN
- discount nike dunks [url=http://www.likedunksb.com]nike sb[/url],[url=http://www.likedunksb.com]discount nike dunks[/url]
- discount nike dunks nike sb,discount nike dunks
on Aug 10, 2009
at 12:54 PM Azn Azn looks tasty at these levels!!!
Article: Seattle Genetics (SGEN) Said Milestone Triggered In MedImmune Collaboration
on Mar 18, 2008
at 09:51 AM Lifecell (LIFC) It was my understanding, that PFE was interested in Lifecell take over. Is this true?
Article: Shire plc (SHPGY) Higher On AstraZeneca Takeover Rumors